These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12530064)

  • 1. Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Anticancer Res; 2002; 22(6A):3191-6. PubMed ID: 12530064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
    Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Goto M; Inohara T; Sugimoto K; Tai Y; Hando T; Tokuda M
    Gynecol Oncol; 2000 Nov; 79(2):230-7. PubMed ID: 11063650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
    Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
    Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival.
    Rosenberg E; Demopoulos RI; Zeleniuch-Jacquotte A; Yee H; Sorich J; Speyer JL; Newcomb EW
    Hum Pathol; 2001 Aug; 32(8):808-13. PubMed ID: 11521224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
    Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
    Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
    Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: an immunohistochemical and serological analysis.
    Darai E; Bringuier AF; Walker-Combrouze F; Fauconnier A; Couvelard A; Feldmann G; Madelenat P; Scoazec JY
    Gynecol Oncol; 1998 Oct; 71(1):122-7. PubMed ID: 9784332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
    Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S
    Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of Cdk inhibitors p27kip1 and p57kip2 in mouse placenta and human choriocarcinoma JEG-3 cells.
    Kim ST; Lee SK; Gye MC
    Placenta; 2005 Jan; 26(1):73-80. PubMed ID: 15664414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.